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A B S T R A C T
Traumatic brain injury (TBI) is the leading cause of death and disability worldwide. Calpains, a family of cysteine
proteases have been implicated in cells death following TBI. Using immunohistochemistry calpain expression was ana-
lyzed in post mortem brain tissue obtained from patients who died after TBI, and findings were compared with the brain
tissue from patients who died from sudden cardiac arrest. In the injured cortex an increase in calpain expression was ob-
served in all resident brain cells: neurons, glial and endothelial cells in comparison to the control group (all p<0.001).
Calpain expression was analyzed in different post-traumatic intervals, from day 0 until 10 days post-injury, in order to
establish a time course of expression in the brain cortex after TBI. Expression was detected in the cortex 5 hours after the
accident, peaked at 72 hours, and substantially reduced by 10 days after TBI. Calpain expression in the cortex signifi-
cantly changed during the time from TBI to death (p<0.001), and the most prominent expression was detected in the cor-
tex 3 days after TBI. Our results indicate that prolonged calpain expression in resident brain cells (neurons, glial and en-
dothelial cells) plays an important role in neuronal degeneration following TBI.
Key words: calpain, neuronal damage, traumatic brain injury, post-mortem study
Introduction
Traumatic brain injury (TBI) is a major cause of
death and disability throughout the world. Solely in the
United States, approximately 52,000 people die and 80,000
people suffer permanent disability as the consequence of
TBI1. The Centers for Disease Control and Prevention
(CDC) estimate that at least 5.3 million Americans cur-
rently have a long-term requirement for assistance with
daily living activities as a result of TBI2.
The primary injury to the brain initiates a secondary
injury process that spreads through multiple molecular
mechanisms in the pathogenesis of TBI.
Calpains are implicated in neuropathologic events fol-
lowing TBI3. Neuronal calpain activation has been de-
tected after experimental TBI in animals, suggesting
that calpains are an early mediator of neuronal damage4.
Calpains are nonlysosomal, neutral cysteine proteas-
es activated by calcium. The best characterized, and the
predominant calpains in the CNS, are the ubiquitous m-
and m-calpains3. These are heterodimers consisting of a
unique 80 kDa large subunit and a common 28 kDa small
subunit4. Cytoskeletal proteins, membrane proteins, and
transcription factors are known to be preferred calpain
substrates3. Upon activation, calpains cleave a variety of
biologically important proteins and serve, therefore, as
key regulators of many cellular functions3,4. Whereas
transient calpain activation triggers numerous cell sig-
naling and remodeling events involved in normal physio-
logical processes, the sustained calpain activation pro-
duced by trauma is associated with neuronal death in
multiple models of TBI5.
In this study we have examined calpain expression in
post mortem brain tissue obtained from patients who
died from TBI and compared the findings with patients
who died from sudden cardiac arrest.
Patients and Methods
The study was performed on cases of fatal TBI sub-
jected to medicolegal autopsy at the Department of Fo-
rensic Medicine and Criminalistics, School of Medicine,
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University of Rijeka. In 50 autopsy cases with TBI and
known survival times, a sample of brain tissue was taken
from the macroscopically visible contusion zone in the
cerebral cortex. The survival time in the TBI group
ranged from 5 h to 10 days. For the control group, brain
tissues were taken from 34 autopsy cases without trau-
ma in which death had resulted from sudden cardiac ar-
rest. Collection and use of human tissue material was ac-
quired according to guidelines and study was approved
by the Institutional Ethics Committee. The ages of the
individuals in the TBI group ranged from 40 to 70 years
(the mean age was 56.3±7.9 years). There were 33 males
and 17 females.
The control group included 22 males and 12 females.
There were no significant differences between TBI pa-
tients and control patients for age or gender distribution:
42–69 years; the mean age 56.3±7.3 years.
Tissue preparation and histologic assessment
The resected brain tissue was immediately fixed in
10% buffered formalin. After fixation in formalin, the
paraffin-embedded tissue was sectioned into 7 µm slices
and then mounted onto polylysine-coated slides. Sections
of each specimen were processed for hematoxylin-eosin
(HE) staining. Control samples were prepared in the
same way. HE slides from the control and TBI group
were submitted for neuropathological evaluation.
Immunohistochemical analysis
Sections of paraffin-embedded samples were proces-
sed for immunohistochemical analysis in a DAKO Auto-
stainer Plus (DakoCytomation Colorado, Fort Collins,
CO, USA) according to the manufacturer’s protocol using
the EnVision peroxidase procedure (ChemMate EnVision
HRP detection kit K5007, DakoCytomation, Glostrup,
Denmark). Microwave antigen retrieval was done in the
presence of 1 mmol/L EDTA (pH 8.0) buffer.
The calpain antibody (Abcam, Cambridge, UK) was
visualized by incubation with biotinylated goat anti-rab-
bit immunoglobulin (DAKO, Glostrup, Denmark). Nega-
tive staining controls comprised sections immunostained
as above apart from omission of the primary antibody.
Semiquantitative scoring
Calpain expression was assessed by immunohistoche-
mistry. All the images were acquired and analyzed on a
light microscope Olympus BX51 (Olympus, Tokyo, Ja-
pan) with camera attached Olympus DP72 (Olympus,
Tokyo, Japan) by two different researchers blinded to the
experimental conditions. For immunohistochemistry, the
intensity of cytoplasmic chromogen staining was graded
semiquantitatively on a scale of 0–3 arbitrary units with
0= no detectable staining, 1= weak, 2= moderate and
3= strong staining6.
Statistical analysis
Statistical analysis was carried out using the Sta-
tistica 9.0 (StatSoft Inc., Tulsa, OK, USA) program. Data
were analyzed using Mann–Whitney test and Spearman
rank correlation test. Results are given as X±SD. Only
p<0.05 values were regarded as significant.
Results
Histopathological analysis
HE sections from the cortex of the TBI group revealed
destruction of the brain parenchyma. At the site of corti-
cal contusion large brain edema was visible, along with
loss of tissue cells, primary neurons. Also, blood extra-
vasation and infiltration of inflammatory cells was de-
tected. The necrotic neurons showed disappear of Nissl’s
body in cytoplasm, chromatolysis, nuclear pyknosis and
eosinophilic cytoplasm (Figure 1). In brain parenchyma
of head injured patients lack of cellular structure was ob-
served in comparison to the control group where brain
parenchyma showed intact morphology.
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Fig. 1. HE staining of the cortex from TBI group. Leptomenin-
geal hematoma and diffuse brain edema (A; magnification:
100x), blood extravasation in the brain parenchyma (B; magnifi-
cation: 200x), perivascular infiltration of inflammatory cells (C;
magnification: 200x) and necrotic eosinophilic neurons (D; mag-





















Fig. 2. Expression of calpain in the cortex of the control and TBI
group. Diagrammatic presentation of semi-quantitative data for
calpain expression analyzed by immunohistochemistry. In the in-
jured cortex stronger calpain immunoreactivity was observed
(p<0.001) compared to control group.
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Immunohistochemical study of calpain expression
Immunohistochemical analysis of calpain expression
was performed on the cortex from the control and TBI
group. In the TBI group immunoreactivity to the calpain
was detected in neurons, glial cells and endothelial cells,
whereas the control group showed very weak calpain
staining. Semi-quantitative analysis showed significant-
ly elevated calpain expression in neurons, glial and endo-
thelial cells in the traumatic brain cortex compared to
control brain (all p<0.001) (Figure 2).
Neurons
In the cortex of TBI group immunohistochemical ana-
lysis showed intense calpain staining in a number of neu-
rons, including pyramidal neurons. Significantly higher
calpain expression in the neurons of TBI group was ob-
served in comparison to the control group (Figure 3).
Glial cells
We have observed a strong calpain staining in the cy-
toplasm of glial cells in the TBI group. Moreover, in the
TBI group expression of calpain in glial cells was almost
equal to one of neurons. A significant increase of calpain
expression in the TBI group was determined in compari-
son to the control group (Figure 3).
Vessels
Endothelial cells of vessels were labeled for calpain in
the TBI group, in contrast to the control group where sel-
dom positive cells were found. Significantly increased cal-
pain expression in endothelial cells was detected in the
TBI group in comparison to the control brain (Figure 3).
Calpain expression in the cortex following TBI
in different post-traumatic intervals
Calpain expression was analyzed in different post-
-traumatic intervals, from day 0 until 10 days post-injury,
in order to establish a time course of expression in the
brain cortex after TBI. Calpain expression was detected
in the cortex 5 hours after the accident, peaked at 72
hours, and substantially reduced by 10 days after TBI.
Calpain expression in the cortex significantly changed
during the time from TBI to death (p<0.001), and the
most prominent expression was detected in the cortex 3
days after TBI (Figure 4).
Correlation between calpain expression in the cortex
and the period of time elapsed from trauma to the brain
death in the TBI group was negative (Spearman rank co-
efficient R) and statistically significant in all resident
brain cells (Table 1).
Discussion and Conclusion
TBI is a major cause of death and one of the most fre-
quent neurological disorders. It is known that TBI re-
sults in a variety of pathological changes following inju-
ry7–9. We have confirmed that TBI results in loss of the
basic cytoarchitecture of the brain causing significant
damage to the brain parenchyma.
The first reports of calpain activation following exper-
imental TBI were published in 1996. Saatman et al.
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Fig. 3. Immunoreactivity for calpain in the cortex following TBI.
Significantly stronger calpain staining was observed in both
neurons () and glial cells () in the TBI group. Also, calpain
staining was observed in endothelial cells (). No calpain stain-
























Fig. 4. Calpain expression in the cortex following TBI in differ-
ent post-traumatic intervals. Calpain expression in the cortex
significantly changed during the time from TBI to death
(p<0.001), and the most prominent expression was detected in
the cortex 3 days after TBI.
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showed that lateral fluid percussion brain injury in the
rat initiates calpain activation in the cortex and hippo-
campus10. Neuronal calpain activation has been observed
within minutes to hours following either contusive or dif-
fuse brain trauma in animals, suggesting that calpains
are an early mediator of neuronal damage5.
In our study calpain expression in the cortex follow-
ing TBI was evaluated by immunohistochemistry. We
have confirmed calpain expression in all resident brain
cells (i.e. neurons, glia and endothelial cells) of the in-
jured brain. Moreover, in the cortex of TBI group signifi-
cantly increased calpain immunoeactivity was detected
in all cell populations in comparison to the control group.
This observation suggests that neuronal survival may be
compromised due to increased expression of calpain in
the injured cortex.
Further, temporal changes in calpain expression fol-
lowing TBI were investigated. In the cortex calpain ex-
pression was recorded at different time points after the
brain injury: expression was detected 5 hours after the
accident, peaked at 72 hours, and substantially reduced
by 10 days after TBI. Calpain expression in the injured
cortex showed clear temporal variations’ leading to as-
sumption that its expression in a temporally restricted
pattern is consistent with a pathological role this prote-
ase has in post-traumatic brain pathology.
Similar results were obtained by the authors who
have studied the temporal expression of calpain in labo-
ratory animals. Pike and colleagues in the rat model of
TBI confirmed that calpain activation occurs during the
first 3–4 hours after TBI and that gradually decreases up
to 7 days after TBI11.
Also, several prospective case control studies of pa-
tients with severe TBI have reported increased levels of
calpain- and caspase-mediated spectrin BDPs in ventric-
ular cerebrospinal fluid from 6 h to 3–4 days after trau-
ma12,13.
According to our study, prolonged calpain activation
plays an important role in neuronal degeneration follow-
ing TBI. Taken together with the previous demonstra-
tion of calpain involvement in the pathogenesis of many
neurological diseases, including cerebral ischemia14, Alz-
heimer’s disease15, Parkinson’s disease16, and amyotro-
phic sclerosis17 these data support the hypothesis that
prolonged calpain activation contributes to post-trau-
matic cell death.
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TABLE 1
CORRELATION BETWEEN CALPAIN EXPRESSION IN THE
CORTEX AND THE PERIOD OF TIME ELAPSED FROM TRAUMA






Glial cells –0.373 0.020
Endothelial cells –0.364 0.025
U:\coll-antropolo\coll-antro-4-2012\12064 Bralic.vp
21. prosinac 2012 9:11:20
Color profile: Disabled
Composite  150 lpi at 45 degrees
IZRA@AJ KALPAINA U KORTEKSU OSOBA PREMINULIH NAKON
TRAUMATSKE OZLJEDE MOZGA
S A @ E T A K
Traumatska ozljeda mozga (TBI) vode}i je uzrok smrti i invalidnosti u svijetu. Poznato je da kalpaini, stani~ne
neutralne cisteinske proteaze, sudjeluju u post-traumatskom o{te}enju mo`danog parenhima. Izra`aj kalpaina u korte-
ksu osoba preminulih nakon TBI i osoba kontrolne skupine koje su umrle uslijed naglog zatajenja u radu srca anali-
ziran je imunohistokemijski. U korteksu osoba preminulih nakon TBI zabilje`en je poja~an izra`aj kalpaina u svim
rezidentnim mo`danim stanicama (neuronima, glija stanicama i endotelnim stanicama) u odnosu na kontrolnu skupi-
nu (svi p<0,001). U razli~itim vremenskim razdobljima proteklim od traume mozga do smrti analiziran je izra`aj kal-
paina kako bi se ispitao vremenski obrazac ekspresije kalpaina u mozgu nakon TBI. Izra`aj kalpaina zabilje`en je u kori
mozga 5 sati nakon ozljede, a najve}a vrijednost je zabilje`ena 3 dana nakon TBI. Statisti~ke analize pokazale su da se
izra`aj kalpaina u korteksu zna~ajno mijenja s vremenom proteklim od traume mozga do smrti (p<0,001). Na{i rezul-
tati ukazuju da poja~an izra`aj kalpaina u stanicama mo`dane kore igra va`nu ulogu u post-traumatskoj neurodege-
neraciji.
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